longevizing recreational drug highs to nonhuman mammals, Enzymatically determined dosage of a recreational drug, herbivores might eat kilograms of dry, slightly moldy, recreational drug containing grass during winter, while other mammals seeking an enjoyable recreational drug experience like bears might eat only grams, a way to make it so a plurality, optimally all species are able to enjoy a harmless recreational drug experience even while eating orders of magnitude different amounts of the plant, fungi, hair oil or hair-saliva product, is to have the drug be a drug that only turns active when liver enzymes activate it, the first grams of what is consumed utilize all of the amount of that particular liver enzyme, then the rest of the drug, perhaps at a wet or moldy grass eater that is eating kilograms, is not converted past the first few grams of the get high dose, that way a bear, a squirrel, a mouse, and a deer can get high off the same plant, fungi, or other organism sourced recreational drug even though they eat different amounts

It is possible different neurotransmitter neuron activations at the nucleus accumbens are differently enjoyable, they could have mice test out different nucleus accumbens neuron and neurotransmitter particular effects and combinations to find which have, to my perception, tremendous enjoyment (fMRI of mice) with mating urge mate presentation able to cause omitting repeat administration, it is beneficial if the self administration of the recreational drug at nonhuman mammals is less than human voluntary repeat administration of caffeine, similar to the tremendously mild repeat use effect at phenibut, while still being voluntarily and enjoyably used

Previously non edible plant parts, pine cones, palm tree bark, maple seeds, sagebrush as well as others, could all have recreational drugs that nonhuman (or humans) mammals enjoy that are harmless and where saliva fluidly and enzymatically releases the drug with 1-3 minutes at the mouth, chewing optional, and with an absence of swallowing

It might be possible to have the living layer of tree bark, the cambium, be a drug neutralizing chemical containing part of plants, then there would mostly be an absence of harm to plants with tree bark at a variety of trees all over the earth containing recreational drugs that nonhuman mammals (as well as humans) enjoy, the nonhuman mammal would omit nibbling the living part of the tree, to preserve their enjoyable high, concentrating only on the nibbling the bark exterior

Longevity technology
Phenibut, a GABA active drug, reduces the appearance of inflammation at dermatitis many double digit %, and to my perception causes more rapid restoration of well dermis, I have read that inflammation is linked to non youthful phenotype, testing phenibut on mice to find out if it is longevizing as well as healthspan increasing, and preserving of youthful phenotype is beneficial, if phenibut does cause longevization as well as, or, greater healthspan then screening molecular variations of phenibut to find the most longevizing, healthspan increasing variations is a beneficial longevity drug, notably there are also GABA active peptides, if screening a library of these peptides finds longevizing as well as, or healthspan increasing versions then gene therapy that produces that peptide is a longevity technology and a one dose atopic dermatitis curing or ameliorating treatment

What is the mechanism of phenibut reducing erythema, itch, and, notably, rapidifying healing at dermatitis, the receptors and gene products of that could be a basis for new antidermatitis drugs, possibly also antiinflammatory longevity drugs, it is possible GABA activity at the peripheral nervous system could be a part of this effect, if variations on peripheral nervous system activity reduce inflammation body wide, more than just at the dermis, then they could find out if peripheral nervous system SNPs and allele variations have longevity effects at humans, epigenetics, gene therapy, as well as new drugs that effect the peripheral nervous system that are beneficial may be possible

AM or PM depot drug activation could be beneficial at administering drugs like the longevity peptide AEDG epithalon, variation at body temperature sleep wake temperature differences might be utilizable, gastrointestinal activity differences, pulse rate average while asleep differences, these various differences combined, as well as full side of body surface continuous contact difference from sleeping (squishable polymer capsule) could all contribute to different am pm drug administration

Longevity drug
Noting time of day, sleep wake cycle responsive drug administration from depot injection could be possible it is possible some longevity drugs like AEDG Epithalon, a pineal peptide have greater longevization activity when repeatedly administered at just part of the sleep wake cycle